CRA was retained by the respondent in an ICC arbitration in which the claimant alleged an inappropriate termination of a supply agreement relating to material used in a vaccine. CRA’s analysis demonstrated that changes in the commercial market circumstances for the final product had eroded the returns to untenable levels, showing that it would be in neither party’s interests to maintain the supply agreement.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...